Chronic Lyme disease

Lyme Disease: An Evidence-Based Approach

Volumn , Issue , 2011, Pages 248-258

  Marques, Adriana ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84890155780     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (91)

1. Adams, W.V., Rose, C.D., Eppes, S.C. and Klein, J.D. (1999) Cognitive effects of Lyme disease in children: a 4 year followup study. Journal of Rheumatology 26, 1190-1194.
2. Aggarwal, V.R., McBeth, J., Zakrzewska, J.M., Lunt, M. and MacFarlane, G.J. (2006) The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors? International Journal of Epidemiology 35, 468-476.
3. Aguero-Rosenfeld, M.E., Wang, G., Schwartz, I. and Wormser, G.P. (2005) Diagnosis of Lyme borreliosis. Clinical Microbiology Reviews 18, 484-509.
4. Alexander, W. (2009) Integrative healthcare symposium: cancer and chronic Lyme disease. Pharmacy and Therapeutics 34, 202-214.
5. Arnez, M., Radsel-Medvescek, A., Pleterski-Rigler, D., Ruzic-Sabljic, E. and Strle, F. (1999) Comparison of cefuroxime axetil and phenoxymethyl penicillin for the treatment of children with solitary erythema migrans. Wiener Klinische Wochenschrift 111, 916-922.
6. Arnez, M., Pleterski-Rigler, D., Luznik-Bufon, T., Ruzic-Sabljic, E. and Strle, F. (2002) Solitary erythema migrans in children: comparison of treatment with azithromycin and phenoxymethylpenicillin. Wiener Klinische Wochenschrift 114, 498-504.
7. Asch, E.S., Bujak, D.I., Weiss, M., Peterson, M.G. and Weinstein, A. (1994) Lyme disease: an infectious and postinfectious syndrome. Journal of Rheumatology 21, 454-461.
8. Barsic, B., Maretic, T., Majerus, L. and Strugar, J. (2000) Comparison of azithromycin and doxycycline in the treatment of erythema migrans. Infection 28, 153-156.
9. Barthold, S.W., Hodzic, E., Imai, D.M., Feng, S., Yang, X. and Luft, B.J. (2010) Ineffectiveness of tigecycline against persistent Borrelia burgdorferi. Antimicrobial Agents and Chemotherapy 54, 643-651.
10. Berglund, J., Stjernberg, L., Ornstein, K., Tykesson-Joelsson, K. and Walter, H. (2002) 5-y Follow-up study of patients with neuroborreliosis. Scandinavian Journal of Infectious Diseases 34, 421-425.
11. Bockenstedt, L.K., Mao, J., Hodzic, E., Barthold, S.W. and Fish, D. (2002) Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment. Journal of Infectious Diseases 186, 1430-1437.
12. Borg, R., Dotevall, L., Hagberg, L., Maraspin, V., Lotric-Furlan, S., Cimperman, J. and Strle, F. (2005) Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis. Scandinavian Journal of Infectious Diseases 37, 449-454.
13. Cameron, D.J. (2006) Generalizability in two clinical trials of Lyme disease. Epidemiologic Perspectives and Innovations 3, 12.
14. Cameron, D. (2009) Obstacles to trials of chronic Lyme disease in actual practice. Minerva MED 100, 435-436.
15. Cerar, D., Cerar, T., Ruzic-Sabljic, E., Wormser, G.P. and Strle, F. (2010) Subjective symptoms after treatment of early Lyme disease. American Journal of Medicine 123, 79-86.
16. Chandra, A., Wormser, G.P., Klempner, M.S., Trevino, R.P., Crow, M.K., Latov, N. and Alaedini, A. (2010) Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms. Brain Behavior and Immunity 24, 1018-1024.
17. Dattwyler, R.J., Halperin, J.J., Volkman, D.J. and Luft, B.J. (1988) Treatment of late Lyme borreliosis -randomised comparison of ceftriaxone and penicillin. Lancet 1, 1191-1194.
18. Dattwyler, R.J., Volkman, D.J., Conaty, S.M., Platkin, S.P. and Luft, B.J. (1990) Amoxycillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis. Lancet 336, 1404-1406.
19. Dattwyler, R.J., Luft, B.J., Kunkel, M.J., Finkel, M.F., Wormser, G.P., Rush, T.J., Grunwaldt, E., Agger, W.A., Franklin, M., Oswald, D., Cockey, L. and Maladorno, D. (1997) Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease. New England Journal of Medicine 337, 289-294.
20. Dattwyler, R.J., Wormser, G.P., Rush, T.J., Finkel, M.F., Schoen, R.T., Grunwaldt, E., Franklin, M., Hilton, E., Bryant, G.L., Agger, W.A. and Maladorno, D. (2005) A comparison of two treatment regimens of ceftriaxone in late Lyme disease. Wiener Klinische Wochenschrift 117, 393-397.
21. Donta, S.T. (1997) Tetracycline therapy for chronic Lyme disease. Clinical Infectious Diseases 25 (Supplement 1), S52-S56.
22. Donta, S.T. (2003) Macrolide therapy of chronic Lyme disease. Medical Science Monitor 9, PI136-PI142.
23. Donta, S.T. (2007) Lyme disease guidelines -it's time to move forward. Clinical Infectious Diseases 44, 1134-1135; author reply 1137-1139.
24. Eppes, S.C. and Childs, J.A. (2002) Comparative study of cefuroxime axetil versus amoxicillin in children with early Lyme disease. Pediatrics 109, 1173-1177.
25. Fallon, B.A., Keilp, J.G., Corbera, K.M., Petkova, E., Britton, C.B., Dwyer, E., Slavov, I., Cheng, J., Dobkin, J., Nelson, D.R. and Sackeim, H.A. (2008) A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 70, 992-1003.
26. Feder, H.M. Jr and Hunt, M.S. (1995) Pitfalls in the diagnosis and treatment of Lyme disease in children. Journal of the American Medical Association 274, 66-68.
27. Feder, H.M. Jr, Johnson, B.J., O'connell, S., Shapiro, E.D., Steere, A.C. and Wormser, G.P. (2007) A critical appraisal of "chronic Lyme disease". New England Journal of Medicine 357, 1422-1430.
28. Fleming, R.V., Marques, A.R., Klempner, M.S., Schmid, C.H., Dally, L.G., Martin, D.S. and Philipp, M.T. (2004) Pre-treatment and posttreatment assessment of the C6 test in patients with persistent symptoms and a history of Lyme borreliosis. European Journal of Clinical Microbiology Infectious Diseases 23: 615-618.
29. Gerber, M.A., Shapiro, E.D., Burke, G.S., Parcells, V.J. and Bell, G.L. (1996) Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group. New England Journal of Medicine 335, 1270-1274.
30. Hickie, I., Davenport, T., Wakefield, D., Vollmer-Conna, U., Cameron, B., Vernon, S.D., Reeves, W.C. and Lloyd, A. (2006) Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. British Medical Association 333, 575.
31. Hodzic, E., Feng, S., Holden, K., Freet, K.J. and Barthold, S.W. (2008) Persistence of Borrelia burgdorferi following antibiotic treatment in mice. Antimicrobial Agents and Chemotherapy 52, 1728-1736.
32. Johnson, M. and Feder, H.M. Jr (2010) Chronic Lyme disease: a survey of Connecticut primary care physicians. Journal of Pediatrics 157, 1205-1209.
33. Kalish, R.A., Kaplan, R.F., Taylor, E., Jones-Woodward, L., Workman, K. and Steere, A.C. (2001) Evaluation of study patients with Lyme disease, 10-20-year follow-up. Journal of Infectious Diseases 183, 453-460.
34. Kaplan, R.F., Trevino, R.P., Johnson, G.M., Levy, L., Dornbush, R., Hu, L.T., Evans, J., Weinstein, A., Schmid, C.H. and Klempner, M.S. (2003) Cognitive function in post-treatment Lyme disease: do additional antibiotics help? Neurology 60, 1916-1922.
35. Katz, B.Z., Shiraishi, Y., Mears, C.J., Binns, H.J. and Taylor, R. (2009) Chronic fatigue syndrome after infectious mononucleosis in adolescents. Pediatrics 124, 189-193.
36. Kindstrand, E., Nilsson, B.Y., Hovmark, A., Pirskanen, R. and Asbrink, E. (2002) Peripheral neuropathy in acrodermatitis chronica atrophicans -effect of treatment. Acta Neurologica Scandinavica 106, 253-257.
37. Klempner, M.S., Hu, L.T., Evans, J., Schmid, C.H., Johnson, G.M., Trevino, R.P., Norton, D., Levy, L., Wall, D., Mccall, J., Kosinski, M. and Weinstein, A. (2001) Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. New England Journal of Medicine 345, 85-92.
38. Klempner, M.S., Wormser, G.H., Wade, K., Trevino, R.P., Tang, J., Kaslow, R.A. and Schmid, C. (2005) A case-control study to examine HLA haplotype associations in patients with posttreatment chronic Lyme disease. Journal of Infectious Diseases 192, 1010-1013.
39. Krause, P.J., Telford, S.R. III, Spielman, A., Sikand, V., Ryan, R., Christianson, D., Burke, G., Brassard, P., Pollack, R., Peck, J. and Persing, D.H. (1996) Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. Journal of the American Medical Association 275, 1657-1660.
40. Krupp, L.B., Hyman, L.G., Grimson, R., Coyle, P.K., Melville, P., Ahnn, S., Dattwyler, R. and Chandler, B. (2003) Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology 60, 1923-1930.
41. Ljostad, U. and Mygland, A. (2010) Remaining complaints 1 year after treatment for acute Lyme neuroborreliosis; frequency, pattern and risk factors. European Journal of Neurology 17, 118-123.
42. Loge, J.H., Ekeberg, O. and Kaasa, S. (1998) Fatigue in the general Norwegian population: normative data and associations. Journal of Psychosomatic Research 45, 53-65.
43. Luft, B.J., Dattwyler, R.J., Johnson, R.C., Luger, S.W., Bosler, E.M., Rahn, D.W., Masters, E.J., Grunwaldt, E. and Gadgil, S.D. (1996) Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial. Annals Internal Medicine 124, 785-791.
44. Luger, S.W., Paparone, P., Wormser, G.P., Nadelman, R.B., Grunwaldt, E., Gomez, G., Wisniewski, M. and Collins, J.J. (1995) Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans. Antimicrobial Agents and Chemotherapy 39, 661-667.
45. Marques, A., Brown, M.R. and Fleisher, T.A. (2009a) Natural killer cell counts are not different between patients with post-Lyme disease syndrome and controls. Clinical and Vaccine Immunology 16, 1249-1250.
46. Marques, A., Shaw, P., Schmid, C.H., Steere, A., Kaplan, R.F., Hassett, A., Shapiro, E. and Wormser, G.P. (2009b) Re: A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Prolonged Lyme disease treatment: enough is enough. Neurology 72, 383-384; author reply 384.
47. Marques, A.R., Hornung, R.L., Dally, L. and Philipp, M.T. (2005) Detection of immune complexes is not independent of detection of antibodies in Lyme disease patients and does not confirm active infection with Borrelia burgdorferi. Clinical and Diagnostic Laboratory Immunology 12, 1036-1040.
48. Marques, A.R., Stock, F. and Gill, V. (2000) Evaluation of a new culture medium for Borrelia burgdorferi. Journal of Clinical Microbiology 38, 4239-4241.
49. Marshall, E. (1999) Lyme disease. Patients scarce in test of long-term therapy. Science 283, 1431.
50. Morphy, H., Dunn, K.M., Lewis, M., Boardman, H.F. and Croft, P.R. (2007) Epidemiology of insomnia: a longitudinal study in a UK population. Sleep 30, 274-280.
51. Nadelman, R.B., Luger, S.W., Frank, E., Wisniewski, M., Collins, J.J. and Wormser, G.P. (1992) Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease. Annals Internal Medicine 117, 273-280.
52. Nowakowski, J., Nadelman, R.B., Sell, R., Mckenna, D., Cavaliere, L.F., Holmgren, D., Gaidici, A. and Wormser, G.P. (2003) Long-term follow-up of patients with culture-confirmed Lyme disease. American Journal of Medicine 115, 91-96.
53. Oksi, J., Nikoskelainen, J., Hiekkanen, H., Lauhio, A., Peltomaa, M., Pitkaranta, A., Nyman, D., Granlund, H., Carlsson, S.A., Seppala, I., Valtonen, V. and Viljanen, M. (2007) Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study. European Journal of Clinical Microbiology Infectious Diseases 26, 571-581.
54. Pfister, H.W., Preac-Mursic, V., Wilske, B., Schielke, E., Sorgel, F. and Einhaupl, K.M. (1991) Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis. Journal of Infectious Diseases 163, 311-318.
55. Picavet, H.S. and Schouten, J.S. (2003) Musculoskeletal pain in the Netherlands: prevalences, consequences and risk groups, the DMC3-study. Pain 102, 167-178.
56. Picha, D., Moravcova, L., Lasikova, S., Holeckova, D. and Maresova, V. (2006) Symptoms of post-Lyme syndrome in long-term outcome of patients with neuroborreliosis. Scandinavian Journal of Infectious Diseases 38, 747-748.
57. Qureshi, M.Z., New, D., Zulqarni, N.J. and Nachman, S. (2002) Overdiagnosis and overtreatment of Lyme disease in children. Pediatric Infectious Diseases Journal 21, 12-14.
58. Ramsey, A.H., Belongia, E.A., Gale, C.M. and Davis, J.P. (2002) Outcomes of treated human granulocytic ehrlichiosis cases. Emerging Infectious Diseases 8, 398-401.
59. Reid, M.C., Schoen, R.T., Evans, J., Rosenberg, J.C. and Horwitz, R.I. (1998) The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study. Annals of Internal Medicine 128, 354-362.
60. Rohrbeck, J., Jordan, K. and Croft, P. (2007) The frequency and characteristics of chronic widespread pain in general practice: a case-control study. British Journal of General Practice 57, 109-115.
61. Rose, C.D., Fawcett, P.T., Gibney, K.M. and Doughty, R.A. (1994) The overdiagnosis of Lyme disease in children residing in an endemic area. Clinical Pediatrics 33, 663-668.
62. Salazar, J.C., Gerber, M.A. and Goff, C.W. (1993) Long-term outcome of Lyme disease in children given early treatment. Journal of Pediatrics 122, 591-593.
63. Schunemann, H.J., Fretheim, A. and Oxman, A.D. (2006) Improving the use of research evidence in guideline development: 9. Grading evidence and recommendations. Health Research Policy and Systems 4, 21.
64. Seltzer, E.G., Gerber, M.A., Cartter, M.L., Freudigman, K. and Shapiro, E.D. (2000) Longterm outcomes of persons with Lyme disease. Journal of the American Medical Association 283, 609-616.
65. Shadick, N.A., Phillips, C.B., Logigian, E.L., Steere, A.C., Kaplan, R.F., Berardi, V.P., Duray, P.H., Larson, M.G., Wright, E.A., Ginsburg, K.S. and Et, A. (1994) The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Annals of Internal Medicine 121, 560-567.
66. Shadick, N.A., Phillips, C.B., Sangha, O., Logigian, E.L., Kaplan, R.F., Wright, E.A., Fossel, A.H., Fossel, K., Berardi, V., Lew, R.A. and Liang, M.H. (1999) Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease. Annals of Internal Medicine 131, 919-926.
67. Shen, S., Shin, J.J., Strle, K., Mchugh, G., Li, X., Glickstein, L.J., Drouin, E.E. and Steere, A.C. (2010) Treg cell numbers and function in patients with antibiotic-refractory or antibioticresponsive Lyme arthritis. Arthritis and Rheumatism 62, 2127-2137.
68. Sigal, L.H. (1990) Summary of the first 100 patients seen at a Lyme disease referral center. American Journal of Medicine 88, 577-581.
69. Skogman, B.H., Croner, S., Nordwall, M., Eknefelt, M., Ernerudh, J. and Forsberg, P. (2008) Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome. Pediatric Infectious Diseases Journal 27, 1089-1094.
70. Smith, R.P., Schoen, R.T., Rahn, D.W., Sikand, V.K., Nowakowski, J., Parenti, D.L., Holman, M.S., Persing, D.H. and Steere, A.C. (2002) Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. Annals Internal Medicine 136, 421-428.
71. Steere, A.C., Hutchinson, G.J., Rahn, D.W., Sigal, L.H., Craft, J.E., Desanna, E.T. and Malawista, S.E. (1983) Treatment of the early manifestations of Lyme disease. Annals of Internal Medicine 99, 22-26.
72. Steere, A.C., Taylor, E., McHugh, G.L. and Logigian, E.L. (1993) The overdiagnosis of Lyme disease. Journal of the American Medical Association 269, 1812-1816.
73. Steere, A.C., Levin, R.E., Molloy, P.J., Kalish, R.A., Abraham, J.R., Liu, N.Y. and Schmid, C.H. (1994) Treatment of Lyme arthritis. Arthritis and Rheumatism 37, 878-888.
74. Straubinger, R.K. (2000) PCR-based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-day postinfection period. Journal of Clinical Microbiology 38, 2191-2199.
75. Straubinger, R.K., Summers, B.A., Chang, Y.F. and Appel, M.J. (1997) Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. Journal of Clinical Microbiology 35, 111-116.
76. Stricker, R.B. (2007) Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with Lyme disease. Clinical Infectious Diseases 45, 149-157.
77. Strle, F., Ruzic, E. and Cimperman, J. (1992) Erythema migrans: comparison of treatment with azithromycin, doxycycline and phenoxymethyl penicillin. Journal of Antimicrobial Chemotherapy 30, 543-550.
78. Strle, F., Preac-Mursic, V., Cimperman, J., Ruzic, E., Maraspin, V. and Jereb, M. (1993) Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings. Infection 21, 83-88.
79. Thorstrand, C., Belfrage, E., Bennet, R., Malmborg, P. and Eriksson, M. (2002) Successful treatment of neuroborreliosis with ten day regimens. Pediatric Infectious Disease Journal 21, 1142-1145.
80. Tilton, R.C., Barden, D. and Sand, M. (2001) Culture of Borrelia burgdorferi. Journal of Clinical Microbiology 39, 2747.
81. van't Leven, M., Zielhuis, G.A., van der Meer, J.W., Verbeek, A.L. and Bleijenberg, G. (2010) Fatigue and chronic fatigue syndrome-like complaints in the general population. European Journal of Public Health 20, 251-257.
82. Wang, T.J., Sangha, O., Phillips, C.B., Wright, E.A., Lew, R.A., Fossel, A.H., Fossel, K., Shadick, N.A., Liang, M.H. and Sundel, R.P. (1998) Outcomes of children treated for Lyme disease. Journal of Rheumatology 25, 2249-2253.
83. Wang, T.J., Liang, M.H., Sangha, O., Phillips, C.B., Lew, R.A., Wright, E.A., Berardi, V., Fossel, A.H. and Shadick, N.A. (2000) Coexposure to Borrelia burgdorferi and Babesia microti does not worsen the long-term outcome of Lyme disease. Clinical Infectious Diseases 31, 1149-1154.
84. Weber, K., Preac-Mursic, V., Neubert, U., Thurmayr, R., Herzer, P., Wilske, B., Schierz, G. and Marget, W. (1988) Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicans. Annals of the New York Academy of Sciences 539, 324-345.
85. Weber, K., Preac-Mursic, V., Wilske, B., Thurmayr, R., Neubert, U. and Scherwitz, C. (1990) A randomized trial of ceftriaxone versus oral penicillin for the treatment of early European Lyme borreliosis. Infection 18, 91-96.
86. Wilske, B., Fingerle, V. and Schulte-Spechtel, U. (2007) Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunology and Medical Microbiology 49, 13-21.
87. Wormser, G.P. and Schwartz, I. (2009) Antibiotic treatment of animals infected with Borrelia burgdorferi. Clinical Microbiology Reviews 22, 387-395.
88. Wormser, G.P., Ramanathan, R., Nowakowski, J., Mckenna, D., Holmgren, D., Visintainer, P., Dornbush, R., Singh, B. and Nadelman, R.B. (2003) Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine 138, 697-704.
89. Wormser, G.P., Dattwyler, R.J., Shapiro, E.D., Halperin, J.J., Steere, A.C., Klempner, M.S., Krause, P.J., Bakken, J.S., Strle, F., Stanek, G., Bockenstedt, L., Fish, D., Dumler, J.S. and Nadelman, R.B. (2006) The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases 43, 1089-1134.
90. Yrjanainen, H., Hytonen, J., Song, X.Y., Oksi, J., Hartiala, K. and Viljanen, M.K. (2007) Anti-tumor necrosis factor-α treatment activates Borrelia burgdorferi spirochetes 4 weeks after ceftriaxone treatment in C3H/He mice. Journal of Infectious Diseases 195, 1489-1496.
91. Yrjanainen, H., Hytonen, J., Hartiala, P., Oksi, J. and Viljanen, M.K. (2010) Persistence of borrelial DNA in the joints of Borrelia burgdorferiinfected mice after ceftriaxone treatment. Acta Pathologica, Microbiologica et Immunologica Scandinavica 118, 665-673.